Onduo Virtual Care Platform
Integrated virtual care for chronic disease management
Company profile
Company profile
Onduo is a virtual care company specializing in chronic disease management with a primary focus on diabetes and hypertension. The company delivers personalized digital health solutions that integrate technology platforms, human coaching, and clinical expertise to help patients better manage their conditions. Onduo's approach combines connected devices, mobile applications, and virtual care teams to provide continuous support and monitoring for individuals with chronic conditions. The platform aims to improve health outcomes while reducing healthcare costs through proactive, data-driven interventions. Onduo serves health plans, employers, and health systems seeking to provide comprehensive virtual care solutions for their members and patients with chronic diseases.
Company description Onduo official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Integrated virtual care for chronic disease management
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Communications medicine · Jul 3, 2025
The User Experience of AI.Med (New York, N.Y.) · Apr 8, 2022
Medication Optimization Among People With Type 2 Diabetes Participating in a Continuous Glucose Monitoring-Driven Virtual Care Program: Prospective Study.JMIR formative research · Apr 5, 2022
A longitudinal study of convergence between Black and White COVID-19 mortality: A county fixed effects approach.Lancet regional health. Americas · Sep 1, 2021
Remote Application and Use of Real-Time Continuous Glucose Monitoring by Adults with Type 2 Diabetes in a Virtual Diabetes Clinic.Diabetes technology & therapeutics · Feb 1, 2021
Impact of Participation in a Virtual Diabetes Clinic on Diabetes-Related Distress in Individuals With Type 2 Diabetes.Clinical diabetes : a publication of the American Diabetes Association · Oct 1, 2020
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Onduo's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies using AI and digital health tools to help patients manage chronic conditions through digital therapeutics, gamified health management, and AI-powered coaching. Covers management of all chronic diseases including diabetes, hypertension, COPD, heart disease, and multi-condition platforms. Includes continuous glucose monitoring (CGM) systems with AI analytics and insulin optimization algorithms.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.